Cargando…
P1250: EU-SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA
Autores principales: | Brown, F., Sloan, S., Helmig-Mason, J., Hinterschied, C., Long, M., Chan, W. K., Shindiapina, P., Leshchenko, V., Edwards, D., Vaddi, K., Scherle, P., Lapalombella, R., Alinari, L., Parekh, S., Baiocchi, R. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431095/ http://dx.doi.org/10.1097/01.HS9.0000847864.21936.f4 |
Ejemplares similares
-
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
por: Brown-Burke, Fiona, et al.
Publicado: (2023) -
Novel targeted therapies for mantle cell lymphoma
por: Alinari, Lapo, et al.
Publicado: (2012) -
USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11
por: Huang, Gang, et al.
Publicado: (2022) -
Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma
por: Masamha, Chioniso Patience, et al.
Publicado: (2016) -
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
por: Mohanty, Atish, et al.
Publicado: (2016)